FDA Approved: VALPROIC ACID — Supplemental Application (QUAGEN PHARMACEUTICALS LLC)

View source ↗

Summary

FDA approves a supplemental application for Valproic acid from Quagen Pharmaceuticals LLC (ANDA 090517).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy
• Migraine

Drugs mentioned

• VALPROIC ACID (Valproic acid)

Snippet

SUPPL AP for VALPROIC ACID (VALPROIC ACID)